EHR interoperability – Clinical Research Made Simple

Common Data Models for EHR Integration in Real-World Evidence Studies

digi — Thu, 24 Jul 2025 14:18:14 +0000

Common Data Models for EHR Integration in Real-World Evidence Studies

Streamlining EHR Integration through Common Data Models for RWE

Electronic Health Records (EHRs) provide a vast source of real-world data (RWD), but differences in formats and terminologies across systems create integration challenges. Common Data Models (CDMs) offer a solution by providing standardized data structures that enable consistent analysis across institutions, regions, and platforms.

This guide explores how pharmaceutical professionals and clinical trial stakeholders can use CDMs to harmonize EHR data, facilitating reliable real-world evidence (RWE) generation for regulatory and scientific purposes.

Why Common Data Models Are Essential:

Inconsistent EHR formats across healthcare systems hinder large-scale observational studies. CDMs solve this problem by:

Defining standard tables and fields (e.g., patient demographics, diagnoses, drug exposures)
Ensuring uniform terminologies (e.g., SNOMED CT, LOINC, RxNorm)
Enabling cross-database analytics with common logic
Supporting reproducible research through aligned metadata

Whether working on safety studies or comparative effectiveness research, CDMs improve data quality and integrity, enhancing GMP compliance when observational results are used to support regulatory filings.

Key Common Data Models Used in EHR Integration:

Here are the most widely adopted CDMs in the pharma and research community:

OMOP (Observational Medical Outcomes Partnership):
- Developed by the Observational Health Data Sciences and Informatics (OHDSI) collaborative
- Captures clinical data in a person-centric format
- Supports standardized vocabularies and cohort definitions
Sentinel Common Data Model:
- Created by the U.S. FDA’s Sentinel Initiative
- Focused on post-marketing safety surveillance
- Includes robust privacy protections and distributed analytics
PCORnet CDM:
- Developed by the Patient-Centered Outcomes Research Institute
- Optimized for patient-centered outcomes and engagement studies
HL7 FHIR (Fast Healthcare Interoperability Resources):
- Not a CDM in the traditional sense, but a data exchange standard
- Enables real-time EHR integration via APIs
- Increasingly used in dynamic RWE platforms

Steps to Implement a Common Data Model for EHR Integration:

To adopt a CDM in your real-world evidence program, follow these steps:

Choose a CDM: Based on study goals, regulatory alignment, and partner ecosystem.
Extract Data: From source EHRs in both structured and unstructured formats.
Transform and Map: Clean and normalize data using extract-transform-load (ETL) pipelines, aligning with the CDM structure.
Standardize Terminologies: Use tools like Usagi for OMOP to map local codes to global standards.
Validate Data Quality: Perform checks on completeness, consistency, and referential integrity.
Deploy Analytics Tools: Utilize cohort builders, statistical engines, and visualization dashboards compatible with the CDM.

For long-term success, integrate CDM workflows into your Pharma SOP templates for reproducibility and compliance.

Regulatory Acceptance of CDM-Based Evidence:

Global regulatory bodies increasingly recognize CDM-aligned evidence in submissions. For example:

The USFDA accepts Sentinel CDM results in drug safety monitoring.
The EMA leverages OMOP-standardized data in DARWIN EU for RWE analysis.
Health Canada encourages structured data submissions to improve review efficiency.

Maintaining traceability from original EHR sources to CDM tables is critical for regulatory audits. Align with data provenance principles to ensure integrity.

Common Challenges and Solutions in CDM Adoption:

Challenge: Mapping diverse data sources with incompatible formats
Solution: Use ETL automation tools like WhiteRabbit and RabbitInAHat (OMOP) for structured mapping
Challenge: Clinical terminologies vary by institution or country
Solution: Leverage SNOMED CT crosswalks and LOINC/RxNorm mappings
Challenge: Governance and access across multi-site collaborations
Solution: Employ federated data models or distributed queries with privacy controls

Build competency by including CDM mapping training in your Pharma Validation programs to improve internal capacity.

Case Example: OMOP CDM in Oncology RWE

In an oncology real-world evidence study, a pharmaceutical sponsor mapped EHR data from five hospitals to the OMOP CDM. They used standardized definitions to:

Identify eligible lung cancer patients
Track treatment regimens and outcomes
Evaluate progression-free survival across treatment cohorts

This enabled fast data extraction and consistent outcome definitions, accelerating the generation of real-world insights aligned with StabilityStudies.in protocols.

Best Practices for Long-Term Sustainability:

Document your ETL pipelines and update them regularly as source EHRs evolve
Use open-source CDM tools to avoid vendor lock-in
Join communities like OHDSI or PCORnet to stay updated on CDM advancements
Align with pharma regulatory compliance for traceable and auditable CDM processes
Incorporate metadata standards to improve data discoverability and reusability

CDM maturity models are emerging to guide institutions through phased adoption. Early wins in pilot projects can build momentum for wider rollouts.

Conclusion: Building RWE Infrastructure through CDMs

As the demand for high-quality real-world evidence grows, integrating EHRs using common data models becomes indispensable. CDMs provide the structure, standardization, and scalability needed to transform raw EHR data into regulatory-grade evidence.

Whether leveraging OMOP, Sentinel, PCORnet, or HL7 FHIR, success lies in methodical implementation, rigorous validation, and strategic alignment with regulatory and scientific goals. With the right approach, CDMs can unlock the full potential of EHRs for next-generation evidence generation in pharmaceuticals.

Using Electronic Health Records (EHRs) in Clinical Research: Opportunities, Challenges, and Best Practices

digi — Sun, 04 May 2025 13:16:30 +0000

Using Electronic Health Records (EHRs) in Clinical Research: Opportunities, Challenges, and Best Practices

Mastering the Use of Electronic Health Records (EHRs) in Clinical Research: Opportunities and Best Practices

Electronic Health Records (EHRs) have revolutionized healthcare delivery and are now playing an increasingly vital role in clinical research. By enabling access to vast amounts of real-world data, EHRs facilitate observational studies, pragmatic trials, safety surveillance, and outcomes research. However, leveraging EHRs for research purposes requires careful attention to data quality, privacy regulations, and methodological rigor. This guide explores the strategies, challenges, and best practices for using EHRs effectively in clinical research.

Introduction to the Use of Electronic Health Records (EHRs)

Electronic Health Records (EHRs) are digital systems for recording patient health information, including medical history, diagnoses, medications, lab results, and treatment plans. EHRs offer a rich source of real-world data (RWD) that can be repurposed for clinical research to generate real-world evidence (RWE). EHR-based studies can inform regulatory approvals, post-marketing surveillance, comparative effectiveness research, and healthcare quality improvement initiatives.

What is the Use of EHRs in Clinical Research?

Using EHRs in clinical research involves extracting, cleaning, analyzing, and interpreting clinical data originally collected during routine healthcare. Researchers can design observational studies, enhance patient recruitment for trials, conduct long-term follow-up assessments, or even integrate EHR data directly into clinical trial workflows (e.g., pragmatic trials). Proper governance, robust methodology, and advanced analytics are crucial for successful EHR-based research.

Key Components / Types of EHR Use in Research

Observational Research: Conduct cohort, case-control, and cross-sectional studies using retrospective or prospective EHR data.
Pragmatic Clinical Trials: Integrate trial protocols into EHR workflows for patient identification, randomization, and outcome measurement.
Safety Surveillance: Monitor adverse events, post-marketing product safety, and rare side effects using EHR systems.
Registries and Longitudinal Studies: Build disease-specific or treatment-specific registries based on EHR data.
Data Linkage: Link EHRs with claims, laboratory, imaging, genomics, or wearable device data for enriched analyses.

How Using EHRs for Research Works (Step-by-Step Guide)

Define Research Objectives: Clearly specify the clinical questions and outcomes to be addressed using EHR data.
Assess Data Availability: Evaluate whether necessary variables (exposures, outcomes, covariates) are captured reliably in the EHR.
Obtain Regulatory Approvals: Secure IRB approvals, data use agreements, and patient consent (where required) under HIPAA/GDPR frameworks.
Extract and Process Data: Use structured queries, natural language processing (NLP), and other techniques to retrieve structured and unstructured data.
Clean and Validate Data: Address missingness, inconsistencies, and coding errors through systematic data cleaning and validation procedures.
Analyze and Interpret: Apply statistical and machine learning methods, considering potential biases and data provenance issues.

Advantages and Disadvantages of Using EHRs in Clinical Research

Advantages	Disadvantages
Enables access to large, diverse, real-world patient populations. Facilitates faster and more cost-efficient evidence generation. Supports longitudinal follow-up and capture of rare outcomes. Enhances trial feasibility and patient recruitment capabilities.	Data quality and completeness vary across sites and systems. Potential for misclassification and missing data. Challenges in harmonizing data across different EHR vendors. Privacy and data governance issues must be carefully managed.

Common Mistakes and How to Avoid Them

Assuming Data Are Research-Ready: Conduct detailed data quality assessments before relying on EHR data for analysis.
Neglecting Data Privacy Requirements: Ensure HIPAA, GDPR, and institutional policies are strictly followed, with appropriate de-identification or anonymization.
Overlooking Unstructured Data: Use advanced text mining or NLP tools to leverage unstructured clinical notes and narratives.
Inadequate Validation: Validate key study variables (e.g., diagnosis codes, outcome definitions) against external gold standards where possible.
Failure to Address Confounding: Apply statistical methods like propensity scores, matching, or multivariable modeling to control for confounders.

Best Practices for Using EHRs in Research

Predefine study protocols and statistical analysis plans specifying EHR data elements, definitions, and handling procedures.
Engage clinical informaticists and data scientists early in the study design process.
Leverage common data models (e.g., OMOP, PCORnet) to facilitate data standardization and multi-site collaborations.
Conduct sensitivity analyses to assess the robustness of findings against data quality limitations.
Report transparently following RECORD-PE (Reporting of studies Conducted using Observational Routinely-collected Data for Pharmacoepidemiology) or other relevant reporting guidelines.

Real-World Example or Case Study

In a large pragmatic trial evaluating hypertension management strategies, EHR data were leveraged to identify eligible patients, document interventions, and collect outcome measures directly through clinical workflows. The use of EHRs allowed rapid enrollment across multiple healthcare systems, reduced trial costs, and provided real-world effectiveness evidence that directly influenced clinical practice guidelines.

Comparison Table

Aspect	EHR-Based Research	Traditional Clinical Trial Data Collection
Data Collection Mode	Secondary use of routine clinical data	Purpose-specific, protocol-driven data collection
Cost and Speed	Lower cost, faster access	Higher cost, slower access
Data Quality	Variable, requires validation	Controlled and monitored
Generalizability	High (real-world populations)	Often limited by strict eligibility criteria

Frequently Asked Questions (FAQs)

1. What is an EHR?

An Electronic Health Record (EHR) is a digital version of a patient’s medical history, maintained by healthcare providers over time.

2. How are EHRs used in clinical research?

EHRs are used to identify study populations, collect exposure and outcome data, conduct observational studies, and support pragmatic trials.

3. What are common challenges when using EHRs for research?

Data incompleteness, variability across systems, lack of standardization, privacy concerns, and misclassification are major challenges.

4. How is patient privacy protected in EHR-based research?

Through data de-identification, encryption, access controls, and adherence to HIPAA, GDPR, and institutional review board (IRB) requirements.

5. What types of studies benefit most from EHR data?

Observational studies, comparative effectiveness research, safety surveillance, and long-term follow-up studies.

6. What is EHR interoperability?

The ability of different EHR systems to exchange, interpret, and use shared data effectively across organizations.

7. How can unstructured EHR data be utilized?

Using natural language processing (NLP) techniques to extract meaningful information from clinical notes, narratives, and free-text entries.

8. What is the OMOP common data model?

The Observational Medical Outcomes Partnership (OMOP) common data model standardizes diverse healthcare data to facilitate research collaboration and reproducibility.

9. Can EHR data support regulatory submissions?

Yes, with proper validation, documentation, and adherence to regulatory agency expectations (e.g., FDA RWE framework, EMA guidance).

10. Are there guidelines for reporting EHR-based studies?

Yes, RECORD-PE and other extensions of STROBE provide frameworks for reporting research based on routinely collected health data.

Conclusion and Final Thoughts

Using Electronic Health Records (EHRs) in clinical research opens new frontiers for real-world evidence generation, offering the potential to accelerate insights, reduce study costs, and enhance healthcare decision-making. Success in EHR-based research hinges on rigorous data validation, strong governance frameworks, and thoughtful study design. At ClinicalStudies.in, we advocate for responsible, innovative use of EHRs to unlock richer, more representative clinical research that benefits patients, providers, and the broader healthcare system.